This article is more than 5 years old. Information may no longer be current.

BMG Pharma launches Ialuxid gel in China for post-surgical wounds

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

BMG Pharma announced it has launched its proprietary Ialuxid gel in the People’s Republic of China for the treatment of post-surgical wounds.

Ialuxid gel, in the version approved in China, is a non-antibiotic microbial gel formulated to create a moist wound environment conducive to healing, especially suitable for post-surgical wounds, according to a company press release. Luqa Pharmaceuticals will distribute the product nationwide, the release stated.

The gel formulation includes hyaluronic acid, glycine and hydrogen peroxide and forms a protective film on the skin to prevent bacterial infections. It is registered in Europe for treating acne lesions, folliculitis, paronychia, Molluscum Contagiosum and impetigo, according to the release.

Reference: www.bmgpharma.com.